427 related articles for article (PubMed ID: 17656116)
1. Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.
Peng G; Wang HY; Peng W; Kiniwa Y; Seo KH; Wang RF
Immunity; 2007 Aug; 27(2):334-48. PubMed ID: 17656116
[TBL] [Abstract][Full Text] [Related]
2. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
3. Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
Devilder MC; Allain S; Dousset C; Bonneville M; Scotet E
J Immunol; 2009 Sep; 183(6):3625-33. PubMed ID: 19710464
[TBL] [Abstract][Full Text] [Related]
4. Functional control of regulatory T cells and cancer immunotherapy.
Wang RF
Semin Cancer Biol; 2006 Apr; 16(2):106-14. PubMed ID: 16423537
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.
Peng G; Guo Z; Kiniwa Y; Voo KS; Peng W; Fu T; Wang DY; Li Y; Wang HY; Wang RF
Science; 2005 Aug; 309(5739):1380-4. PubMed ID: 16123302
[TBL] [Abstract][Full Text] [Related]
6. CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.
Wang RF
Hum Immunol; 2008 Nov; 69(11):811-4. PubMed ID: 18817828
[TBL] [Abstract][Full Text] [Related]
7. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
Jasani B; Navabi H; Adams M
Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
[TBL] [Abstract][Full Text] [Related]
8. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
Guo BL; Liu Z; Aldrich WA; Lopez RD
Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
[TBL] [Abstract][Full Text] [Related]
9. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
Hilchey SP; Bernstein SH
Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
[TBL] [Abstract][Full Text] [Related]
10. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK and lowers the threshold of T-helper cell type 1 responses.
Bohnenkamp HR; Papazisis KT; Burchell JM; Taylor-Papadimitriou J
Cell Immunol; 2007 Jun; 247(2):72-84. PubMed ID: 17927969
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptors and immune regulation: implications for cancer therapy.
Wang RF; Miyahara Y; Wang HY
Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
[TBL] [Abstract][Full Text] [Related]
12. Regulatory T cells and Toll-like receptors in tumor immunity.
Wang RF; Peng G; Wang HY
Semin Immunol; 2006 Apr; 18(2):136-42. PubMed ID: 16469504
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived γδ regulatory T cells suppress innate and adaptive immunity through the induction of immunosenescence.
Ye J; Ma C; Hsueh EC; Eickhoff CS; Zhang Y; Varvares MA; Hoft DF; Peng G
J Immunol; 2013 Mar; 190(5):2403-14. PubMed ID: 23355732
[TBL] [Abstract][Full Text] [Related]
15. The significance of Treg cells in defective tumor immunity.
Kosmaczewska A; Ciszak L; Potoczek S; Frydecka I
Arch Immunol Ther Exp (Warsz); 2008; 56(3):181-91. PubMed ID: 18512029
[TBL] [Abstract][Full Text] [Related]
16. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours.
Conroy H; Marshall NA; Mills KH
Oncogene; 2008 Jan; 27(2):168-80. PubMed ID: 18176598
[TBL] [Abstract][Full Text] [Related]
17. Activation of Toll-like receptor 4 on tumor cells in vitro inhibits subsequent tumor growth in vivo.
Andreani V; Gatti G; Simonella L; Rivero V; Maccioni M
Cancer Res; 2007 Nov; 67(21):10519-27. PubMed ID: 17974996
[TBL] [Abstract][Full Text] [Related]
18. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
19. The expanding universe of regulatory T cell subsets in cancer.
Gajewski TF
Immunity; 2007 Aug; 27(2):185-7. PubMed ID: 17723212
[TBL] [Abstract][Full Text] [Related]
20. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
